Gian Seehra

Octopus Ventures, part of Octopus Group, is one of the largest and most active venture capital investors in the UK and Europe. We’re on a mission to invest in the people, ideas and industries that will change the world. We back entrepreneurs ─ from the first cheque their business receives, right through to IPO. We manage £1.8bn and are investing in more than 200 businesses, focusing on the companies solving three of the world’s biggest problems: those building a sustainable planet, empowering people, and revitalising healthcare. We know what it takes to build a successful business. We support founders through our strong teams, sector expertise and deep networks, using our people and talent to help them build a better tomorrow.

QVentures is a Venture Capital firm providing direct investment opportunities. QVentures sources, screens, and invests in top-tier start-ups from Seed to Series C. QVentures has participated in rounds with an aggregate combined size of over £220m in 115 companies. Our team is experienced with deep knowledge of the UK venture ecosystem and our focus lies on high-growth, revenue-generating companies raising Seed to Series C investment rounds. QVentures advises on a Pre-Seed Fund which backs the next generation of best-in-breed technology founders in the UK. If you are looking to invest £100k+ in early-stage companies, request information at www.qventures.co/register If you are an entrepreneur seeking funding, please apply here https://qventures.typeform.com/to/zZPOWf -- Investing in early-stage businesses involves risks, including illiquidity (the inability to sell assets quickly or without substantial loss in value), lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. QVentures is a trading name of Quintessentially Ventures Limited, which is an Appointed Representative of Brooklands Fund Management Limited which is authorised and regulated by the Financial Conduct Authority (FRN 757575).

Trait Biosciences Inc. is a leading biotechnology research organization providing proprietary technology to enable safer, lower cost, predictable, and superior quality cannabinoid products. With a world-class team of scientists collaborating in a state-of-the-art Los Alamos laboratory, Trait Biosciences researchers are unlocking new breakthroughs in cannabinoid science. Trait Biosciences offers transformative technologies that create water-soluble cannabinoids, increase cannabinoid production, protect the plants from disease, tailor the production of cannabinoids and that can assure zero THC for hemp. Our solutions have broad applications across industries. Visit www.traitbio.com to learn more.

Pebble Labs Inc. is creating safe and effective biological solutions to sustainably protect yields and quality in food production. We harness naturally occurring microbes from the microbiomes of crops of interest to deliver the power of RNA for solutions that target formidable pests and diseases. We are proud to be supported by Unreasonable Impact!

Pitch Deck advice that results in investor meetings. Investment process help to secure an investment. Honest feedback and actionable insights on pitch decks and fundraising from an experienced entrepreneur and investor.

Octopus Ventures, part of Octopus Group, is one of the largest and most active venture capital investors in the UK and Europe. We’re on a mission to invest in the people, ideas and industries that will change the world. We back entrepreneurs ─ from the first cheque their business receives, right through to IPO. We manage £1.8bn and are investing in more than 200 businesses, focusing on the companies solving three of the world’s biggest problems: those building a sustainable planet, empowering people, and revitalising healthcare. We know what it takes to build a successful business. We support founders through our strong teams, sector expertise and deep networks, using our people and talent to help them build a better tomorrow.

QVentures is a Venture Capital firm providing direct investment opportunities. QVentures sources, screens, and invests in top-tier start-ups from Seed to Series C. QVentures has participated in rounds with an aggregate combined size of over £220m in 115 companies. Our team is experienced with deep knowledge of the UK venture ecosystem and our focus lies on high-growth, revenue-generating companies raising Seed to Series C investment rounds. QVentures advises on a Pre-Seed Fund which backs the next generation of best-in-breed technology founders in the UK. If you are looking to invest £100k+ in early-stage companies, request information at www.qventures.co/register If you are an entrepreneur seeking funding, please apply here https://qventures.typeform.com/to/zZPOWf -- Investing in early-stage businesses involves risks, including illiquidity (the inability to sell assets quickly or without substantial loss in value), lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. QVentures is a trading name of Quintessentially Ventures Limited, which is an Appointed Representative of Brooklands Fund Management Limited which is authorised and regulated by the Financial Conduct Authority (FRN 757575).

Trait Biosciences Inc. is a leading biotechnology research organization providing proprietary technology to enable safer, lower cost, predictable, and superior quality cannabinoid products. With a world-class team of scientists collaborating in a state-of-the-art Los Alamos laboratory, Trait Biosciences researchers are unlocking new breakthroughs in cannabinoid science. Trait Biosciences offers transformative technologies that create water-soluble cannabinoids, increase cannabinoid production, protect the plants from disease, tailor the production of cannabinoids and that can assure zero THC for hemp. Our solutions have broad applications across industries. Visit www.traitbio.com to learn more.

Pebble Labs Inc. is creating safe and effective biological solutions to sustainably protect yields and quality in food production. We harness naturally occurring microbes from the microbiomes of crops of interest to deliver the power of RNA for solutions that target formidable pests and diseases. We are proud to be supported by Unreasonable Impact!